Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2015 Dec 23;77(2):349–356. doi: 10.1007/s00280-015-2944-z

Fig. 1.

Fig. 1

p53 transfection inhibits osteosarcoma cell proliferation. The wild type p53 and green fluorescent protein (GFP) fusion protein expression vector pGFP-p53 was transfected into U-2OS/U-2OSR2 (wild type p53, Wt-p53) and KHOS/KHOSR2 (mutant p53, Mt-p53) cells. Cells were plated in 96-well plates and cultured. Cell proliferation was determined by MTT assay. Results were calculated from five (n=5) repeated experiments with triplicate wells to reflect STD/SEM.